Research programme: glucokinase stimulants - Hua Medicine/RocheAlternative Names: GKA programme - Hua Medicine/Roche; Glucokinase activator programme - Hua Medicine/Roche; RO 0281675
Latest Information Update: 30 Oct 2013
At a glance
- Originator Roche
- Developer Hua Medicine; Roche
- Class Acrylamides; Small molecules
- Mechanism of Action Glucokinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus